A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Type 2 Diabetic Subjects With Microalbuminuria
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
This study is a randomized, placebo-controlled, double-blind, multi-center study to evaluate
efficacy and safety of different doses of CS-3150 compared to placebo in Japanese Type 2
Diabetes Mellitus and Microalbuminuria.
The Primary endpoint is the change from baseline in urinary albumin to creatine ratio (UACR).